webleads-tracker

EFPIA

Transparence Europe | Les génériques aussi : EGA adopts disclosure requirements !

Frank Hernandez, directeur associé de Market iT et membre du Think Tank Loi Bertrand, vous présente le Disclosure Code adopté par l’association européenne des entreprises de génériques. L’EGA (European Generic and biosimilar medicines Association) a adopté le 15 Janvier dernier un Disclosure Code assez similaire à celui adopté par l’EFPIA, avec néanmoins quelques différences. Ce Disclosure Code impose aux membres de l’EGA (adhérents directs ou adhérents via leur association locale comme le GEMME en France) de publier les transferts de valeurs directs et indirects avec les HCO et les HCP, hors dépenses de repas et boissons comme pour l’EFPIA, mais …

Read More »

EFPIA | Les laboratoires pharmaceutiques face aux exigences de transparence

Selon une enquête réalisée par Veeva Systems en 2015, plus de 60% des entreprises de l’industrie pharmaceutique ne sont pas complètement prêtes à répondre aux exigences de transparence de l’EFPIA. En Juin 2016, tous les laboratoires pharmaceutiques dans les pays membres de l’EFPIA, la Fédération européenne des associations et industries pharmaceutiques, devront publier leurs transferts de valeurs aux professionnels et organismes de santé : les frais d’inscription, d’hospitalité et d’honoraires des consultants, les dons et des subventions… La première publication sera faite le 30 Juin 2016 pour les paiements effectués en 2015. Cette information sera publiée sur une plate-forme publique, …

Read More »

Working Hard Toward Better Transparency

Sunshine Act

The very best clinical practice does not take place in a vacuum. It requires input and expertise from many groups: clinicians; patient organisations; academics; healthcare organisations; and the manufacturers of new medicines and medical technology. Collaboration between my industry and these important customers results in three main benefits: 1. Making new medicines possible in the first place; 2. Providing vital health education needed to ensure that medicines are used appropriately; and 3. Capturing patient insights into current treatments and understanding unmet medical needs. The adoption of the EFPIA Healthcare Professional (HCP)/Healthcare Organisation (HCO) Disclosure Code will deliver long awaited financial …

Read More »

EFPIA : All Roads Lead to Consent

The European Pharmaceutical Industry Association (EFPIA) has preempted government sunshine regulations in Europe by providing a holistic approach to disclosing transfers of value between healthcare professionals (HCPs) and organizations (HCOs) for its 40+ members in 33+ countries. In 2016, EFPIA members will have to publicly disclose any transfer of value captured in 2015 on a per country basis. As a part of this process, EFPIA country member associations will have to ensure that standard EFPIA requirements conform to state or local data privacy regulations. To read the article by Véronique Monjardet

Read More »

EFPIA | Reflections on disclosure at ECC2015

Sunshine Act

As we pack up the stand after four fascinating days at the European Cancer Congress 2015, I have a little time to reflect on some of the conversations we have had on industry’s move to disclose publicly payments to health professionals. The first observation is that despite the first disclosures being scheduled for the second quarter of 2016, there are still many individuals in the medical community and even some in the industry that are not yet aware of this transformational step in the relationship between industry and the health professionals we work with. We had a number of conversations …

Read More »

UK HCPs back transparency over their pharma payments

sunsgine act

A poll of healthcare professionals (HCPs) in the UK has found that a majority believe payments made by pharma companies should be made public. The survey of more than 500 doctors, nurses, hospital specialists and pharmacists, commissioned by the Association of the British Pharmaceutical Industry (ABPI), indicated that 87% of respondents felt payments should be transparent. To read the article by Phil Taylor

Read More »